Literature DB >> 26163642

Increasing Incidence of Colorectal Cancer, Starting at a Younger Age for Rectal Compared to Colon Cancer in Brunei Darussalam.

Vui Heng Chong1, Pemasari Upali Telisinghe, Ian Bickle, Muhamad Syafiq Abdullah, Ediwn Lim, Chee Fui Chong.   

Abstract

BACKGROUND: Colorectal cancer (CRC) is the most common gastrointestinal malignancy and is a significant cause of mortality. Its incidence is generally increasing in Asia. Reports from the West have indicated that the incidence of rectal cancer is increasing in the younger population. This study assessed the time trend of CRC in Brunei Darussalam specifically assessing the different age groups at which the incidences start to increase.
MATERIALS AND METHODS: The National Cancer registry was reviewed (1991 to 2014). The age standardized rate (ASR) and the age specific incidence rates (ASIRs) for three time periods (1991-1998), (1999-2006) and (2007-2014) were calculated.
RESULTS: The mean age of diagnosis was 59.3±14.6 years old, incidences being slightly higher amongst men (57.6%) and Malays (67.1%). The most common tumor type was adenocarcinoma (96.4%). Rectal cancers accounted for 35.2% (n=372/1,056) of all cancers of the large bowel; more men were affected than women. The proportion of rectal cancer was also high among the indigenous group. In the three time periods, the ASR for CRC increased from 16 per 100,000 (1991-1998) to 19.6 per 100,000 (1999-2006) and 24.3 per 100,000 (2007-2014). The ASIRs for CRC increased markedly between the time periods 1998-2006 and 2007-2014, beginning in the 40-44 years age group. For rectal cancers, the ASIRs started to increase in the 25-29 age group onward whereas for colon cancers, the increase was observed at a later age, starting from the 45-49 age group.
CONCLUSIONS: Our study showed an increase in the incidence of CRC including in the younger age groups. The increase was seen earlier in rectal cancer compared to colon cancer. These data mirror the trends reported from the West.

Entities:  

Mesh:

Year:  2015        PMID: 26163642     DOI: 10.7314/apjcp.2015.16.12.5063

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  6 in total

1.  Nomogram predicting cancer-specific mortality in early-onset rectal cancer: a competing risk analysis.

Authors:  Yufeng Wang; Jiayuan Wu; Hairong He; Huan Ma; Liren Hu; Jiyu Wen; Jun Lyu
Journal:  Int J Colorectal Dis       Date:  2020-02-20       Impact factor: 2.571

2.  A systematic review of methods to estimate colorectal cancer incidence using population-based cancer registries.

Authors:  Norah Alsadhan; Alaa Almaiman; Mar Pujades-Rodriguez; Cathy Brennan; Farag Shuweihdi; Sultana A Alhurishi; Robert M West
Journal:  BMC Med Res Methodol       Date:  2022-05-19       Impact factor: 4.612

3.  Efficacy and safety of nivolumab for metastatic biliary tract cancer.

Authors:  Miaomiao Gou; Yong Zhang; Haiyan Si; Guanghai Dai
Journal:  Onco Targets Ther       Date:  2019-01-25       Impact factor: 4.147

Review 4.  Colorectal Cancer in Brunei Darussalam: An Overview and Rationale for National Screening Programme.

Authors:  Mei Ann Lim; Vui Heng Chong; Sok King Ong; Ya Chee Lim
Journal:  Asian Pac J Cancer Prev       Date:  2019-12-01

5.  Survival of colorectal cancer patients in Brunei Darussalam: comparison between 2002-09 and 2010-17.

Authors:  Shirley H F Lee; Hanif Abdul Rahman; Nadiah Abidin; Sok King Ong; Elvynna Leong; Lin Naing
Journal:  BMC Cancer       Date:  2021-04-30       Impact factor: 4.430

6.  Risk of Colorectal Carcinoma May Predispose to the Genetic Variants of the GST, CYP450, and TP53 Genes Among Nonsmokers in the Saudi Community.

Authors:  Ikhlas A Sindi; Ahmed O Babalghith; Mohammed T Tayeb; Ahmad H Mufti; Hind Naffadi; Samar N Ekram; Ezzeldin N Elhawary; Munaifah Alenezi; Nasser A Elhawary
Journal:  Int J Gen Med       Date:  2021-04-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.